Eli Lilly to build new $6.5 billion orforglipron manufacturing facility in Texas
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
The facility has been classified as Voluntary Action Indicated
Merck opens first climate-neutral manufacturing facility in Ireland
The inspection concluded with zero form 483 observations
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Subscribe To Our Newsletter & Stay Updated